PROFESSOR KINGSTON MILLS is Professor of Experimental Immunology at TCD. He has said that vaccinating the entire Irish population is needed to generate herd immunity for Covid-19. In 2016, Mills began work on a €28 million project to find a vaccine for whooping cough.
He was co-founder of Opsoma Therapeutics with Luke O’Neill. Opsona Therapeutics, one of the most heavily backed Irish biotech start-ups, is to be wound up after 14 years in which it raised more than €76,500.000 in funding. A decision was taken to put the company into a creditors’ voluntary liquidation after the search for a development partner or buyer for its main drug therapy was fruitless. – 13 Jan 2019
Kingston Mills – more here on Opsona Therapeutics through the years